SandraChaparroMDFACC

Cardiology • Miami, FL

Heart Failure & Transplantation, Cardiac Critical Care

Director of Advanced Heart Failure

Join to view full profile

Dr. Chaparro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chaparro's full profile

Already have an account?

Office
Miami Cardiac and Vascular Institute
7400 SW 87 Avenue Suite 100
Miami, FL 33173
Phone+1 786-204-4204

Fax+1 305-274-7812

Education & Training

Cleveland Clinic FoundationFellowship, Advanced Heart Failure and Transplant Cardiology, 2007 - 2008
University of Missouri-ColumbiaFellowship, Cardiovascular Disease, 2004 - 2007
University of Missouri-ColumbiaResidency, Internal Medicine, 2001 - 2004
Stanford Health Care-Sponsored Stanford UniversityPost-Doctoral Fellowship, Infectious Disease, 1997 - 2001
Escuela Colombiana de MedicinaClass of 1997

Certifications & Licensure

FL State Medical License 2008 - 2026
OH State Medical License 2007 - 2008
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
National Board of Physicians and Surgeons Advanced Heart Failure and Transplant
National Board of Physicians and Surgeons Cardiovascular Disease
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Clinical Trials

Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure Start of enrollment: 2007 Mar 01
Completed
Phase 1, Phase 2
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT) Start of enrollment: 2008 Aug 01
Terminated
Phase 2, Phase 3
A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction Start of enrollment: 2010 Apr 14
Active, not recruiting
Phase 2
Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure Start of enrollment: 2010 Apr 01
Completed
Phase 2
C-Pulse® System: A Heart Assist Device Clinical Study Start of enrollment: 2012 Sep 12
Terminated
Not Applicable
Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
No longer available
A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure. Start of enrollment: 2014 Feb 14
Completed
Phase 3
Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH ) Start of enrollment: 2014 Jul 16
Completed
Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) Start of enrollment: 2014 Jun 04
Terminated
Phase 2
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation Start of enrollment: 2014 Sep 01
Terminated
Not Applicable
CardioMEMS HF System Post Approval Study Start of enrollment: 2015 Jan 01
Completed
SHIELD II Clinical Investigation Start of enrollment: 2015 Aug 01
Terminated
Not Applicable
Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury Start of enrollment: 2020 Jan 01
Suspended
Phase 2, Phase 3
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19) Start of enrollment: 2020 Dec 23
Terminated
Phase 1, Phase 2
PROACTIVE-HF IDE Trial Heart Failure NYHA Class III Start of enrollment: 2020 Jan 10
Active, not recruiting
Not Applicable
Surveillance HeartCare® Outcomes Registry Start of enrollment: 2018 Dec 28
Active, not recruiting
Assessment of CCM in HF With Higher Ejection Fraction Start of enrollment: 2022 Feb 03
Recruiting
Not Applicable
COMMUNITY STUDY- A Study to Collect Information for the Cordio System Start of enrollment: 2015 Oct 20
Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III Start of enrollment: 2023 Nov 29
Recruiting
Not Applicable
TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater TR Start of enrollment: 2017 Aug 01
Active, not recruiting
Not Applicable
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR Start of enrollment: 2018 Jan 01
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

36 citations
Combined use of Impella left ventricular assist device and extracorporeal membrane oxygenation as a bridge to recovery in fulminant myocarditis.
Sandra Chaparro, Apurva Badheka, George R. Marzouka, Tanyanan Tanawuttiwat, Fayaz Ahmed
ASAIO Journal. 2012-05-01
9 citations
Phosphodiesterase-5 Inhibitors and Outcomes During Left Ventricular Assist Device Support: A Systematic Review and Meta-Analysis.
Veraprapas Kittipibul, Vanessa Blumer, Natthapon Angsubhakorn, Gabriel A. Hernandez, Sandra Chaparro
Journal of Cardiac Failure. 2020-12-29
101 citations
Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.
Shao Zhou Gao, Sandra Chaparro, Mark G. Perlroth, Jose G. Montoya, Joan Miller
The Journal of Heart and Lung Transplantation. 2003-05-01

Journal Articles

Clinical Research Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis
Gabriel A Hernandez, Sandra Chaparro, Jeffrey J Goldberger, ScienceDirect

Other

First in Southeast US to use heart failure device
Chaparro, Sandra MD, UMiami
http://med.miami.edu/news/uhealth-becomes-first-in-southeast-us-to-use-new-heart-failure-monitoring-s
University of Miami - 10/20/2014

Press Mentions

Moderate or Vigorous Exercise May Boost Heart Health, Large Study FindsSeptember 1st, 2022
Transplanting Pig Hearts into Humans Offers Promise – and PerilJanuary 14th, 2022
What to Know About MyocarditisJuly 23rd, 2021
Join now to see all